APA (7th ed.) Citation

Severa, M., Rizzo, F., Sinigaglia, A., Ricci, D., Etna, M. P., Cola, G., . . . Coccia, E. M. (2023). A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients. Clinical & translational immunology, 12(3), e1434-n/a. https://doi.org/10.1002/cti2.1434

Chicago Style (17th ed.) Citation

Severa, Martina, et al. "A Specific Anti‐COVID‐19 BNT162b2 Vaccine‐induced Early Innate Immune Signature Positively Correlates with the Humoral Protective Response in Healthy and Multiple Sclerosis Vaccine Recipients." Clinical & Translational Immunology 12, no. 3 (2023): e1434-n/a. https://doi.org/10.1002/cti2.1434.

MLA (9th ed.) Citation

Severa, Martina, et al. "A Specific Anti‐COVID‐19 BNT162b2 Vaccine‐induced Early Innate Immune Signature Positively Correlates with the Humoral Protective Response in Healthy and Multiple Sclerosis Vaccine Recipients." Clinical & Translational Immunology, vol. 12, no. 3, 2023, pp. e1434-n/a, https://doi.org/10.1002/cti2.1434.